Ordering of Ceftazidime for intravitreal or ophthalmic administration is RESTRICTED to the OS for compounded ophthalmic formulations using clinical decision support. Only the 2 mg/0.1 ml concentration for intravitreal use and the 50 mg/mlconcentration for ophthalmic use that have been approved are allowed for use.
Ordering of Ceftazidime for intravitreal or ophthalmic administration is RESTRICTED to the OS for compounded ophthalmic formulations using clinical decision support. Only the 2 mg/0.1 ml concentration for intravitreal use and the 50 mg/ml concentration for ophthalmic use that have been approved are allowed for use.